Oropharyngeal Neoplasms Clinical Trial
Official title:
Analgesia of Fibula Free Flap Donor Site by Peri-Neuronal Catheter in Oro-Pharyngeal Carcinoma Surgery: Comparing Continuous Infusion of Local Anesthetic With Systemic Multimodal Analgesia
This trial examines the analgesia of the fibula free flap donor site by peri-neuronal catheter in oro-pharyngeal carcinoma surgery by comparing continuous infusion of a local anesthetic with systemic multimodal analgesia.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03239834 -
Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-Making
|
||
Recruiting |
NCT00251381 -
Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.
|
Phase 2 | |
Completed |
NCT03074110 -
Isocapnic Hyperventilation - an Alternative Method
|
N/A | |
Enrolling by invitation |
NCT04266093 -
Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies
|
||
Recruiting |
NCT02792322 -
Robotic Surgery in the Seated Position for Benign and Malignant Lesions of the Head and Neck
|
N/A | |
Active, not recruiting |
NCT00918710 -
Human Papillomavirus and Oropharynx Carcinoma
|
N/A | |
Recruiting |
NCT05412628 -
Investigating the Association Between Microbiota and Esophageal/Oropharyngeal Cancer
|
N/A | |
Recruiting |
NCT04124198 -
Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma
|
N/A | |
Completed |
NCT00721799 -
F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients
|
Phase 2 | |
Terminated |
NCT04015336 -
E7 TCR Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal Cancer
|
Phase 2 | |
Withdrawn |
NCT04044950 -
A Phase II Study of Neoadjuvant E7 TCR T Cell Immunotherapy for Borderline Resectable and Unresectable Stage I HPV-Associated Oropharyngeal Cancer
|
Phase 2 | |
Completed |
NCT02262247 -
A Post-Market Clinical Trial for Access and Visualization of the Oropharynx, Hypopharynx and Larynx During Transoral Procedures
|
N/A | |
Terminated |
NCT01687413 -
Post Operative Adjuvant Therapy De-intensification Trial for Human Papillomavirus-related, p16+ Oropharynx Cancer
|
Phase 3 | |
Completed |
NCT01530997 -
De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca
|
Phase 2 | |
Completed |
NCT03010813 -
A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic Surgery
|
N/A | |
Completed |
NCT03077243 -
P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC
|
Phase 2 | |
Terminated |
NCT02045186 -
Monitoring of Oral Human Papillomavirus Infection (HPV) in HPV-positive Oropharyngeal Squamous Cell Carcinoma (OPSCC)
|
N/A | |
Withdrawn |
NCT02298595 -
Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell Carcinoma
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT02281955 -
De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study
|
Phase 2 | |
Terminated |
NCT01525927 -
Study of Chemotherapy Prior to Radiotherapy and Chemotherapy in Patients With HPV Associated Cancer of the Oral Cavity
|
Phase 2 |